JP2019536802A5 - - Google Patents

Download PDF

Info

Publication number
JP2019536802A5
JP2019536802A5 JP2019529901A JP2019529901A JP2019536802A5 JP 2019536802 A5 JP2019536802 A5 JP 2019536802A5 JP 2019529901 A JP2019529901 A JP 2019529901A JP 2019529901 A JP2019529901 A JP 2019529901A JP 2019536802 A5 JP2019536802 A5 JP 2019536802A5
Authority
JP
Japan
Prior art keywords
cntfr
polypeptide
pharmaceutical composition
composition according
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019529901A
Other languages
English (en)
Japanese (ja)
Other versions
JP7257680B2 (ja
JP2019536802A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/064883 external-priority patent/WO2018106790A1/en
Publication of JP2019536802A publication Critical patent/JP2019536802A/ja
Publication of JP2019536802A5 publication Critical patent/JP2019536802A5/ja
Application granted granted Critical
Publication of JP7257680B2 publication Critical patent/JP7257680B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019529901A 2016-12-06 2017-12-06 毛様体神経栄養因子受容体リガンド結合剤およびその使用方法 Active JP7257680B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662430757P 2016-12-06 2016-12-06
US62/430,757 2016-12-06
US201762481027P 2017-04-03 2017-04-03
US62/481,027 2017-04-03
PCT/US2017/064883 WO2018106790A1 (en) 2016-12-06 2017-12-06 Ciliary neurotrophic factor receptor ligand-binding agents and methods of using the same

Publications (3)

Publication Number Publication Date
JP2019536802A JP2019536802A (ja) 2019-12-19
JP2019536802A5 true JP2019536802A5 (https=) 2021-01-21
JP7257680B2 JP7257680B2 (ja) 2023-04-14

Family

ID=62491581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019529901A Active JP7257680B2 (ja) 2016-12-06 2017-12-06 毛様体神経栄養因子受容体リガンド結合剤およびその使用方法

Country Status (8)

Country Link
US (2) US11208462B2 (https=)
EP (1) EP3551648A4 (https=)
JP (1) JP7257680B2 (https=)
KR (1) KR102667654B1 (https=)
CN (2) CN110234660B (https=)
AU (1) AU2017370653B2 (https=)
CA (1) CA3045925A1 (https=)
WO (1) WO2018106790A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4028044A4 (en) * 2019-09-10 2023-09-27 The Board of Trustees of the Leland Stanford Junior University Methods of treating kras mutant cancers
MA71452A (fr) * 2022-07-12 2025-04-30 Regeneron Pharmaceuticals, Inc. Anticorps dirigés contre le récepteur du facteur neurotrophique ciliaire (cntfr) et leurs procédés d'utilisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5426177A (en) * 1990-06-01 1995-06-20 Regeneron Pharmaceuticals, Inc. Ciliary neurotrophic factor receptor
CN1061623A (zh) * 1990-06-01 1992-06-03 里珍纳龙药品有限公司 睫状神经营养性因子受体
IT1284867B1 (it) * 1996-07-10 1998-05-22 Angeletti P Ist Richerche Bio Varianti del fattore neurotrofico ciliare umano (hcntf) con uno spettro di azione differente dalla molecola di tipo selvatico
MXPA03007839A (es) * 2001-03-02 2003-12-08 Merck Patent Gmbh Factor neurotrofico ciliar modificaco con inmunogenicidad reducida.
US20080254451A1 (en) * 2004-12-28 2008-10-16 Ares Trading S.A. Compositions and Methods for Treating Schizophrenia and Related Disorders
CN100457778C (zh) * 2005-09-02 2009-02-04 中国药品生物制品检定所 睫状神经营养因子(cntf)突变体及其生产方法和其用途
DE102011104822A1 (de) * 2011-06-18 2012-12-20 Christian-Albrechts-Universität Zu Kiel Ciliary-Neutrophic-Factor-Varianten

Similar Documents

Publication Publication Date Title
Shen et al. Anti‐cancer therapy with TNF α and IFN γ: A comprehensive review
JP2020169191A5 (https=)
EP2343081A1 (en) Interferon analogs
HRP20231570T1 (hr) Peptid za uporabu u imunoterapiji protiv nesitnostaničnog raka pluća i sitnostaničnog raka pluća
JP2020023567A5 (https=)
JP2010500399A5 (https=)
JP2012500001A5 (https=)
JP2011523857A5 (https=)
JP2020505955A5 (https=)
JP2018503668A5 (https=)
JP2008530245A5 (https=)
JP2014521684A5 (https=)
US7993636B2 (en) Tumor necrosis factor-alpha mutants
WO2009150284A9 (es) Conjugados de apo-a para la administración de compuestos biológicamente activos
JP2015509707A5 (https=)
JP2021533789A5 (https=)
JP2020517658A5 (https=)
JP2008542399A5 (https=)
JP2020519230A5 (https=)
CA3117137A1 (en) Il13ra2 peptide and its uses
JP2019536802A5 (https=)
US20210000895A1 (en) Exosome targeting of cd4+ expressing cells
AU2022221434A1 (en) Therapeutic multi-targeting constructs and uses thereof
JP2013529178A5 (https=)
JP2020530300A5 (https=)